Efficacy and safety of newer P2Y

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 24 citations in OpenAlex.

1. The efficacy and safety of ticagrelor and prasugrel versus clopidogrel in post-PCI dual antiplatelet therapy in chronic coronary syndrome: a systematic review and meta-analysis.BMC cardiovascular disorders · 2026
   Pooled it
2. De-Escalation Dual Antiplatelet Therapy Prevail over Potent P2Y12 Inhibitor Monotherapy in Patients with Acute Coronary Syndrome Undergone Percutaneous Coronary Intervention: A Network Meta-Analysis.Reviews in cardiovascular medicine · 2022
   Pooled it
3. Early vs. Delayed Initiation of Treatment With P2YFrontiers in cardiovascular medicine · 2022
   Pooled it
4. Identification of salvianolic acid A as an ADP receptor-selective and Gq/IPChinese medicine · 2025
   Article
5. Comparative Efficacy and Safety of Novel Antiplatelets and Standard Therapy in Patients With Coronary Artery Disease.Cureus · 2024
   Review
6. Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the Week.Journal of the American College of Cardiology · 2024
   Review
7. Potent P2YCJC open · 2024
   Review
8. Efficacy and safety of cangrelor as compared to ticagrelor in patients with ST-elevated myocardial infarction (STEMI): a systematic review and meta-analysis.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
   Review
9. Comparative efficacy of exercise therapy and oral non-steroidal anti-inflammatory drugs and paracetamol for knee or hip osteoarthritis: a network meta-analysis of randomised controlled trials.British journal of sports medicine · 2023
   Article
10. A Cardiologists' Survey on the Use of Anticoagulants and Antiplatelets in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Those Undergoing Percutaneous Coronary Intervention in India.Cureus · 2023
    Article
11. Vascular Closure Devices after Femoral Arteriotomy: Insight in High-Risk Patients.Journal of the American Heart Association · 2023
    Article
12. Time from blood draw to multiple electrode aggregometry and association with platelet reactivity.Journal of thrombosis and thrombolysis · 2023
    Observational
13. Antiplatelet Therapy Aims and Strategies in Asian Patients with Acute Coronary Syndrome or Stable Coronary Artery Disease.Journal of clinical medicine · 2022
    Review
14. Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI.Scientific reports · 2021
    Article
15. Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998-2018.Scientific reports · 2021
    Article
16. Global antiplatelet sales trend: A focus on P2Y12 inhibitors from 2008 to 2018.American heart journal plus : cardiology research and practice · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 2 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as